A new test, which is called the “wise blood tester” that is detecting aggressive prostate cancer from a blood sample, can save thousands of lives.
It can show when a tumor is a type that can quickly spread to the body, suggests research.
The test identifies prostate cancer patients with aggressive forms of the disease whose death risk is ten times higher than men with relatively slow, slow-to-to-survive malignant tumors.
This allows doctors to personalize treatments given to the individual at an early stage, say scientists at Mary Mary’s London University.
The test is one of the first in a series of ‘liquid biopsies’ that experts believe will revolutionize cancer treatment.